Transforming Drug Development for Neurological Disorders: Proceedings from a Multidisease Area Workshop
出版年份 2023 全文链接
标题
Transforming Drug Development for Neurological Disorders: Proceedings from a Multidisease Area Workshop
作者
关键词
-
出版物
Neurotherapeutics
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-10-12
DOI
10.1007/s13311-023-01440-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Evidence from ClinicalTrials.gov on the growth of Digital Health Technologies in neurology trials
- (2023) Lars Masanneck et al. npj Digital Medicine
- Toward Bridging Unmet Medical Need in Early Alzheimer’s Disease: An Evaluation of Beta‐Amyloid (Aβ) Plaque Burden as a Potential Drug Development Tool
- (2022) Hao Zhu et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Biomarkers in Medicines Development—From Discovery to Regulatory Qualification and Beyond
- (2022) Natalie M. Hendrikse et al. Frontiers in Medicine
- Potential disease-modifying therapies for Huntington's disease: lessons learned and future opportunities
- (2022) Sarah J Tabrizi et al. LANCET NEUROLOGY
- A biological classification of Huntington's disease: the Integrated Staging System
- (2022) Sarah J Tabrizi et al. LANCET NEUROLOGY
- Six Action Steps to Address Global Disparities in Parkinson Disease
- (2022) Nicoline Schiess et al. JAMA Neurology
- Mobilizing the clinical trial ecosystem to drive adoption of master protocols
- (2022) Abby Bronson et al. Clinical Trials
- Amyotrophic Lateral Sclerosis Clinical Trials and Interpretation of Functional End Points and Fluid Biomarkers
- (2022) Jeremy M. Shefner et al. JAMA Neurology
- Model‐Informed Approach Supporting Drug Development and Regulatory Evaluation for Rare Diseases
- (2022) Ruo‐Jing Li et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Effective Data Sharing as a Conduit for Advancing Medical Product Development
- (2021) Stephen R. Karpen et al. Therapeutic Innovation & Regulatory Science
- Alzheimer’s Dementia: The Emerging Role of Positron Emission Tomography
- (2021) Shailendra Mohan Tripathi et al. NEUROSCIENTIST
- Digital Progression Biomarkers as Novel Endpoints in Clinical Trials: A Multistakeholder Perspective
- (2021) Diane Stephenson et al. Journal of Parkinsons Disease
- Four distinct trajectories of tau deposition identified in Alzheimer’s disease
- (2021) Jacob W. Vogel et al. NATURE MEDICINE
- Value of Data Sharing to Advance Drug Development: A Regulatory Perspective
- (2021) Aliza Thompson et al. Therapeutic Innovation & Regulatory Science
- Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease
- (2021) Dallas P. Veitch et al. Alzheimers & Dementia
- Volumetric MRI-Based Biomarkers in Huntington's Disease: An Evidentiary Review
- (2021) Kirsi M. Kinnunen et al. Frontiers in Neurology
- Recommendations to Optimize the Use of Volumetric MRI in Huntington's Disease Clinical Trials
- (2021) Kirsi M. Kinnunen et al. Frontiers in Neurology
- Is It Possible to Conduct a Multi-Arm Multi-Stage Platform Trial in Parkinson’s Disease: Lessons Learned from Other Neurodegenerative Disorders and Cancer
- (2020) Marie-Louise Zeissler et al. Journal of Parkinsons Disease
- Views of European Drug Development Stakeholders on Treatment Optimization and Its Potential for Use in Decision-Making
- (2020) Robbe Saesen et al. Frontiers in Pharmacology
- Serum neurofilament light as a biomarker in progressive multiple sclerosis
- (2020) Raju Kapoor et al. NEUROLOGY
- Magnetic Resonance Spectroscopy in ALS
- (2019) Sanjay Kalra Frontiers in Neurology
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- The Traumatic Brain Injury Endpoints Development (TED) Initiative: Progress on a Public-Private Regulatory Collaboration To Accelerate Diagnosis and Treatment of Traumatic Brain Injury
- (2017) Geoffrey T. Manley et al. JOURNAL OF NEUROTRAUMA
- Multicenter prospective longitudinal study of magnetic resonance biomarkers in a large duchenne muscular dystrophy cohort
- (2016) Rebecca J. Willcocks et al. ANNALS OF NEUROLOGY
- The future is now: Model-based clinical trial design for Alzheimer's disease
- (2015) K Romero et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Coalition Against Major Diseases/European Medicines Agency biomarker qualification of hippocampal volume for enrichment of clinical trials in predementia stages of Alzheimer's disease
- (2014) Derek L.G. Hill et al. Alzheimers & Dementia
- Public-private partnerships need honest brokering
- (2012) Michel Goldman NATURE MEDICINE
- Accelerating Identification and Regulatory Approval of Investigational Cancer Drugs
- (2011) Laura J. Esserman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started